Anti-idiotype cancer vaccines: Past and future

Cancer Immunology Immunotherapy

Volumn 43, Issue 2, 1996, Pages 65-76

  Herlyn, Dorothee ^a   Somasundaram, Rajasekharan ^a   Li, Weiping ^a   Maruyama, Haruhiko ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

anti idiotypic; antibody; antigen; clinical; tumor

Indexed keywords

CANCER VACCINE; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN IDIOTYPE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; TUMOR ANTIGEN;

CANCER IMMUNOTHERAPY; CLINICAL TRIAL; HUMAN; IMMUNOMODULATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; CANCER VACCINES; HUMANS; IMMUNOTHERAPY, ACTIVE;

EID: 0029805370     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050305     Document Type: Review

References (105)

1. Herlyn D, Koprowski H (1988) Anti-idiotypic antibodies in cancer therapy. In: Bona CA (ed) Elicitation and use of anti-idiotypic antibodies and their biological applications. CRC, Boca Raton, Fla, p 123
2. Hamby CB, Liao SK, Kanamaru T, Ferrone S (1987) Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts. Cancer Res 47: 5284
3. Wettendorff M, Koprowski H, Herlyn D (1990) Modulation of anti-tumor immunity with anti-idiotypic antibodies. In: Cerny J, Hiernaux J (eds) Idiotypic network and diseases. Am Soc Microbiol, Washington, DC, p 203
4. Morton DL, Holmes EC, Eilber FR (1982) Adjuvant immunotherapy of malignant melanoma: results of a randomized trial in patients with lymph node metastases. In: Terry WD, Rosenberg SA (eds) Immunotherapy of human cancer. Elsevier North Holland, New York, p 245
5. Herlyn M, Koprowski H (1988) Melanoma antigens: immunological and biological characterization and clinical significance. Annu Rev Immunol 6: 283
6. Ross AH, Herlyn D, Iliopoulos D, Koprowski H (1986) Isolation and characterization of a carcinoma-associated antigen. Biochem Biophys Res Commun 135: 297
7. Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J (1995) Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J Natl Cancer Inst 87: 982
8. Nisonoff A, Lamoy E (1981) Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production. Clin Immunol Immunopathol 21: 397
9. Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol 125: 373
10. Stein KE, Soderstrom T (1984) Neonatal administration of idiotype or anti-idiotype primes for protection against Escherichia coli K13 infection in mice. J Exp Med 160: 1001
11. Herlyn D, Wettendorff M, Schmoll E, Iliopoulos D, Schedel I, Dreikhausen U, Raab R, Ross AH, Jaksche H, Scriba M, Koprowski H (1987) Anti-idiotype immunization of cancer patients: modulation of the immune response. Proc Natl Acad Sci USA 84: 8055
12. Herlyn D, Wettendorff M, Iliopoulos D, Schmoll E, Schedel I, Koprowski H (1989) Modulation of cancer patients' immune responses by administration of anti-idiotypic antibodies. Viral Immunol 2: 271
13. Loibner H, Plot R, Rot An, Werner G, Wrann M, Samonigg H, Schmid M, Stoger H, Truschnig M, Herlyn D, Koprowski H (1990) Immunoreactivity of patient with colorectal cancer metastasis after immunisation with anti-idiotypes. Lancet 335: 171
14. Samonigg H, Wilders-Truschnig M, Loibner H, Plot R, Rot A, Kuss I, Werner G, Stoger H, Wrann M, Herlyn D, Koprowski H (1992) Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibody. Clin Immunol Immunother 65: 271
15. Herlyn D, Benden A, Kane M, Somasundaram R, Zaloudik J, Sperlagh M, Marks G, Hart E, Ralph C, Wettendorff M, Mastrangelo M (1991) Anti-idiotype cancer vaccines: pre-clinical and clinical studies. In Vivo 5: 615
16. Somasundaram R, Zaloudik J, Jacob L, Benden A, Sperlagh M, Hart E, Marks G, Kane M, Mastrangelo M, Herlyn D (1995) Induction of antigen-specific T and B cell immunity in colon carcinoma patients by anti-idiotypic antibody. J Immunol 155: 3253
17. Herlyn D, Harris D, Zaloudik J, Sperlagh M, Maruyama H, Jacob L, Kieny M-P, Scheck S, Somasundaram R, Hart E, Ertl H, Mastrangelo M (1994) Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients. J Immunother 15: 303
18. Wettendorff M, Iliopoulos D, Tempero M, Kay D, DeFreitas E, Koprowski H, Herlyn D (1989) Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A. Proc Natl Acad Sci USA 86: 3787
19. Raychaudhury S, Saeki Y, Chen J-J, Iribe H, Fuji H, Kohler H (1987) Tumor-specific idiotype vaccines. II. Analysis of the tumor-related response induced by the tumor and by internal image antigens (Ab2β). J Immunol 139: 271
20. Raychaudhury S, Saeki Y, Chen J-J, Kohler H (1987) Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells. J Immunol 139: 2096
21. Raychaudhury S, Saeki Y, Fuji H, Kohler H (1986) Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen. J Immunol 137: 1743
22. Saeki Y, Chen J-J, Shi L, Kohler H (1989) Idiotypic intramolecular help. Induction of tumor-specific antibodies by monoclonal anti-idiotypic antibody with the help of Fc-specific T helper clones. J Immunol 142: 2629
23. Köhler H, Raychaudhuri S, Chen J-J (1992) Tumor idiotype vaccines: correlation of the idiotype-recognizing T-cell repertoire with tumor growth. Vaccine Res 1: 33
24. Herlyn D, Powe J, Ross AH, Herlyn M, Koprowski H (1985) Inhibition of human tumor growth by IgG2a monoclonal antibodies correlates with antibody density on tumor cells. J Immunol 134: 1300
25. Lane DP (1992) Cancer: p53, guardian of the genome. Nature 358: 15
26. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M (1987) Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327: 298
27. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704
28. Humphrey PA, Wong AJ, Vogelstein B, Zalutsky MR, Fuller GN, Archer GE, Friedman HS, Kwatra MM, Bigner SH, Bigner DD (1990) Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci USA 87: 4207
29. Herlyn D, Wettendorff M, Iliopoulos D, Koprowski H (1988) Functional mimicry of tumor-associated antigens by anti-idiotypic antibodies. Exp Clin Immunogenet 5: 165
30. Herlyn D, Ross AH, Iliopoulos D, Koprowski H (1987) Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A. Eur J Immunol 17: 1649
31. Koido T, Scheck S, Herlyn D (1995) Induction of immunity to colon carcinoma antigen CO17-1A by monoclonal anti-idiotype (Ab2): effects of Ab2 fragmentation, carrier, and adjuvant. Tumor Targeting 1: 115
32. Herlyn D, Koprowski H (1982) IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc Natl Acad Sci USA 79: 4751
33. Herlyn D, Herlyn M, Steplewski Z, Koprowski H (1985) Monoclonal antihuman tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells. Cell Immunol 92: 105
34. Herlyn D, Lubeck M, Sears HF, Koprowski H (1985) Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibody. J Immunol Methods 85: 27
35. Herlyn D, Jacob L, Somasundaram R (1995) Cancer vaccines: preclinical studies: In: Devita V, Helman S, Rosenberg SA (eds) Biologic therapy of cancer. Lippincott, Philadelphia, Pa, p 625
36. Maruyama H, Benden A, Li W, Zaloudik J, Koido T, Taupin JL, Acres B, Somasundram R, Prewett M, Herlyn D (1996) Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733. Int J Cancer 65: 547
37. Kahn M, Hellstrom I, Estin CHD, Hellstrom KE (1989) Monoclonal anti-idiotypic antibodies related to the p97 human melanoma antigen. Cancer Res 49: 3157
38. Denton GWL, Durrant LG, Hardcastle JD, Austin EB, Sewell HF, Robins RA (1994) Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody. Int J Cancer 57: 10
39. Robins RA, Denton GWL, Hardcastle JD, Austin EB, Baldwin RB, Durrant LG (1991) Antitumor immune responses and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody. Cancer Res 51: 5425
40. Durrant LG, Buckley TJD, Denton GWL, Hardcastle JD, Sewell HF, Robins RA (1994) Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7. Cancer Res 54: 4837
41. Mittleman A, Chen ZJ, Yang H, Wong GY, Ferrone S (1992) Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc Natl Acad Sci USA 89: 466
42. Tsujisaki M, Hinoda Y, Tokuchi S, Hanzawa Y, Arimura Y, Masuya J, Kitagawa H, Okochi E, Shimamura T, Hamuro J, Imai K, Yachi A (1993) The analysis of internal image-bearing anti-idiotypic monoclonal antibody in relation to carcinoembryonic antigen. J Immunol 150: 508
43. Herlyn D, Somasundaram R, Jacob L, Li W, Zaloudik J, Maruyama H, Bender A, Harris D, Mastrangelo M (1996) Anti-idiotypic antibodies that mimic the colorectal cancer antigen CO17-1A/GA733: twelve years of preclinical and clinical studies. In: Shoenfeld I, Kennedy R, Ferrone S (eds) Idiotypes in medicine - infections, autoimmunity and cancer. Elsevier Pergamon, Holland (in press)
44. Fields BA, Goldbaum FA, Ysern X, Poljak RJ, Mariuzza RA (1995) Molecular basis of antigen mimicry by an anti-idiotope. Nature 374: 739
45. Caton AJ, Herlyn D, Ross AH, Koprowski H (1990) Identical D region sequences expressed by murine monoclonal antibodies specific for a human tumor-associated antigen. J Immunol 144: 1965
46. Minden P, Sharpton TR, McClatchy K (1976) Shared antigens between human malignant melanoma cells and mycobacterium bovis (BCG). J Immunol 116: 1407
47. Chen Z-J, Yang H, Liu C, Hirai S, Ferrone S (1993) Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen. Cancer Res 53: 112
48. Herlyn D, Zaloudik J, Somasundaram R, Jacob L, Benden A, Mastrangelo MJ (1993) Anti-idiotype vaccine in colorectal cancer patients. Hybridoma 12: 515
49. Strassburg CP, Kasai Y, Seng BA, Zaloudik J, Herlyn D, Koprowski H, Linnenbach AJ (1992) Baculovirus recombinant expressing a secreted form of a trans-membrane carcinoma-associated antigen. Cancer Res 52: 815
50. Forstrom JW, Nelson KA, Nepom GT, Hellstrom I, Hellstrom KE (1983) Immunization to a syngeneic sarcoma by a monoclonal auto-anti-idiotypic antibody. Nature 303: 627
51. Nelson KA, George E, Swenson C, Forstrom JW, Hellstrom KE (1987) Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells. J Immunol 139: 2110
52. Dunn PL, Johnson CA, Styles JM, Pease SS, Dean CJ (1987) Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge. Immunology 60: 181
53. Sasaki J-I, Tamagake T, Narita S, Ahsan CR (1990) Idiotype vaccine for tumor by anti-idiotypic antibody prepared against anti-(bacillus Calmette Guérin)BCG monoclonal antibody. Cancer Immunol Immunother 31: 273
54. Lee VK, Harriot TM, Kuchroo VK, Halliday WJ, Hellstrom I, Hellstrom KE (1985) Monoclonal anti-idiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity. Proc Natl Acad Sci USA 82: 6286
55. Lee VK, Hellstrom KE, Nepom GT (1986) Idiotypic interactions in immune responses to tumor-associated antigens. Biochim Biophys Acta 865: 127
56. Kennedy RC, Dreesman GR, Butel JS, Lanford RE (1985) Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med 161: 1432
57. Shearer MH, Lanford RI, Kennedy RC (1990) Monoclonal anti-idiotypic antibodies induce humoral immune responses specific for simian virus 40 large tumor antigen in mice. J Immunol 145: 932
58. Shearer MH, Bright RK, Kennedy RC (1993) Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype. Cancer Res 53: 5734
59. Myers WL, El-Zein A (1989) Protection against a syngeneic mammary adenocarcinoma by administration of idiotypic and anti-idiotypic antibodies. Immunol Invest 18: 937
60. H7283-encoded antibodies directed to a murine embryonic carbohydrate antigen, Lewis Y, as ascertained by syngenic anti-idiotype monoclonal antibodies. J Immunol 145: 224
61. Minamizuka T, Eto H, Nakata M, Yagita H, Okumura K (1992) Effect of immunization with anti-idiotypic antibody to melanoma antigen on lung metastasis in mice. Arch Jpn Chir 61: 413
62. Herlyn D, Ross AH, Koprowski H (1986) Anti-idiotypic antibodies bear the internal image of a human tumor antigen. Science 232: 100
63. Irvine K, Schlom J (1993) Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72. Cancer Immunol Immunother 36: 281
64. Losman MJ, Monestier M, Hansen HJ, Goldenberg DM (1990) Baboon anti-idiotype antibodies mimic a carcinoembryonic antigen epitope. Int J Cancer 46: 310
65. Bhattacharya-Chatterjee M, Mukerjee S, Biddle W, Foon KA, Kohler H (1990) Murine monoclonal anti-idiotype antibody as a potential network antigen for human CEA. J Immunol 145: 2758
66. Chakraborty M, Foon KA, Kohler H, Bhattacharya-Chatterjee M (1995) Preclinical evaluation in nonhuman primates of an anti-idiotypic antibody that mimicks the carcinoembryonic antigen. J Immunother 18: 95
67. Durrant LG, Denton GWL, Jacobs E, Mee M, Moss R, Austin EB, Baldwin RW, Hardcastle JD, Robins RA (1992) An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumors. Int J Cancer 50: 811
68. Gaida F-J, Fenger U, Wagener C, Neumaier M (1992) A monoclonal anti-idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen. Int J Cancer 51: 459
69. Losman MJ, Novick KE, Goldenberg DM, Monestier M (1994) Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti-idiotype antibody. Int J Cancer 56: 580
70. Losman MJ, Hansen HJ, Sharkey RM, Goldenberg DM, Monestier M (1991) Human response against NP-4, a mouse antibody to carcinoembryonic antigen: human anti-idiotype antibodies mimic an epitope on the tumor antigen. Proc Natl Acad Sci USA 88: 3421
71. Austin EB, Robins RA, Baldwin RW, Durrant LG (1991) Induction of delayed hypersensitivity to human tumor cells with a human monoclonal anti-idiotypic antibody. J Natl Cancer Inst 83: 1245
72. Durrant LG, Doran M, Austin EB, Robins RA (1995) Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian human tumours. Int J Cancer 61: 62
73. Nepom GT, Nelson KA, Holbeck SL, Hellstrom I, Hellstrom KE (1984) Induction of immunity to a human tumor marker in vivo by administration of anti-idiotypic antibodies in mice. Proc Natl Acad Sci USA 81: 2864
74. D3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody. J Clin Invest 88: 186-192
75. Saleh MN, Stapleton JD, Khazaeli MB, LoBuglio AF (1993) Generation of a human anti-idiotypic antibody that mimics the GD2 antigen. J Immunol 151: 3390
76. Yamamoto S, Yamamoto T, Saxton RE, Hoon DSB, Irie RF (1990) Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3. J Natl Cancer Inst 82: 1757
77. Kusama M, Kageshita T, Zhi JCH, Ferrone S (1989) Characterization of syngeneic anti-idiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies. J Immunol 143: 3844
78. Chen ZJ, Yang H, Yamada M, Kageshita T, Zheng Y, Bae JW, Mittelman A, Ferrone S (1990) Murine anti-idiotypic monoclonal antibodies which bear the mirror image of human high molecular weight-melanoma associated antigen (HMW-MAA). Characterization and applications. In: Lotze MT, Finn OJ (eds) Cellular immunity and the immunotherapy in patients with melanoma, Wilsey-Liss, New York, p 351
79. Chattopadhyay P, Sneed D, Rosenberg J, Starkey J, Robertson N, Leonard J, Raychaudhuri S (1991) Monoclonal anti-idiotypic antibodies to human melanoma-associated proteglycan antigen: generation and characterization of anti-idiotype antibodies. Cancer Res 51: 3183
80. Chattopadhyay P, Starkey J, Raychaudhuri S (1991) Analysis of anti-tumor antibodies in mice and rabbits induced by monoclonal anti-idiotope antibodies. J Immunol 147: 2055
81. Chen ZJ, Yang H, Ferrone S (1991) Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. J Immunol 147: 1082
82. Chattopadhyay P, Starkey J, Morrow WJW, Raychaudhuri S (1992) Murine monoclonal anti-idiotope antibody breaks unresponsiveness and induces a specific antibody response to human melanoma-associated proteoglycan antigen in cynomologus monkeys. Proc Natl Acad Sci USA 89: 2684
83. D2 anti-idiotypic monoclonal antibodies. Int J Cancer 54: 499
84. Viale G, Grassi F, Pelagi M, Alzani R, Menard S, Miotti S, Buffa R, Gini A, Siccardi AG (1987) Anti-human tumor antibodies induced in mice and rabbits by "internal image" anti-idiotypic monoclonal immunoglobulins. J Immunol 139: 4250
85. Viale G, Flamini G, Grassi F, Buffa R, Natali PG, Pelagi M, Leoni F, Menrad S, Siccardi AG (1989) Idiotypic replica of an anti-human tumor associated antigen monoclonal antibody. J Immunol 143: 4338
86. Smorodinsky NI, Ghendler Y, Bakimer R, Chaitchuk S, Keydar I, Shoenfeld Y (1988) Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies. Eur J Immunol 18: 1713
87. Chakraborty M, Mukerjee S, Foon KA, Kohler H, Ceriani RL, Bhattacharya-Chatterjee M (1995) Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody. Cancer Res 55: 1525
88. Schmitt H, Khazaeli MB, Rodenburg CM, Kaul S, Basten G (1994) Production of mouse monoclonal anti-idiotypic antibodies specific to epitopes of tumor-associated mucin TAG-12. Hybridoma 13: 389
89. Uemura H, Okajima E, Derbruyne FMJ, Oosterwijk E (1994) Immunization with anti-idiotype monoclonal antibodies bearing the internal image of the renal-cell carcinoma-associated antigen G250 induces specific cellular immune response. Int J Cancer 59: 802
90. Uemura H, Beniers AJMC, Okajima E, Derbruyne FMJ, Oosterwijk E (1994) Vaccination with anti-idiotype antibodies mimicking a renal cell carcinoma-associated antigen induces tumor immunity. Int J Cancer 58: 555
91. Barth A, Waibel R, Stahel RA (1989) Monoclonal anti-idiotypic antibody mimicking a tumor-associated sialoglycoprotein antigen induces humoral immune response against human small-cell lung carcinoma. Int J Cancer 43: 896
92. Warren RQ, Tsang KY (1990) Induction of immunity to a human osteosarcoma-associated antigen in mice using anti-idiotypic antibodies. Clin Immunol Immunopathol 56: 334
93. Bhattacharya-Chatterjee M, Pride MW, Seon BK, Kohler H (1987) Idiotype vaccines against human T cell acute lymphoblastic leukemia. J Immunol 139: 1354
94. Bhattacharya-Chatterjee M, Chaterjee SK, Vasile S, Seon BK, Kohler H (1988) Idiotype vaccines against human T cell leukemia. II. Generation and characterization of a monoclonal idiotype cascade (Ab1, Ab2, and Ab3). J Immunol 141: 1398
95. Okazaki M, Haruta Y, Shi L, Seon BL (1990) Generation of monoclonal anti-idiotype antibody which express internal images of TALLA, a T acute lymphoblastic leukemia antigen. Am Assoc Cancer Res 31: 279
96. Pohl C, Renner C, Schwonzen M, Sieber M, Lorenz P, Pfreundschuh M, Diehl V (1992) Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immunity across species barriers against CD30 antigen by murine monoclonal internal image antibodies. Int J Cancer 50: 958
97. Pohl C, Renner C, Schwonzen M, Schobert I, Liebenberg V, Jung W, Wolf J, Pfreundschuh M, Diehl V (1993) CD30-specific Ab1-Ab2-Ab3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma. Int J Cancer 54: 418
98. Fagerberg J, Steinitz M, Wigzell H, Askelöf P, Mellstedt H (1995) Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients. Proc Natl Acad Sci USA 92: 4773
99. Foon KA, Chakraborty M, John WJ, Sherratt A, Kohler H, Bhattacharya-Chatterjee M (1995) Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. J Clin Invest 96: 334
100. Mittelman A, Chen ZJ, Kagesita T, Yang H, Yamada M, Baskind P, Goldberg N, Puccio C, Ahmed T, Arlin Z, Ferrone S (1990) Active specific immunotherapy in patients with melanoma. A clinical trial with mouse anti-idiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies. J Clin Invest 86: 2136
101. Ferrone S, Kageshita T, Hirai S (1993) Active specific immunotherapy of malignant melanoma with anti-idiotypic monoclonal antibodies. J Dermatol 20: 533
102. Mittelman A, Chen ZJ, Liu CC, Hirai S, Ferrone S (1994) Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Cancer Res 54: 415
103. Bhattacharya-Chatterjee M, Foon KA, Köhler H (1994) Idiotypic antibody immunotherupy of cancer. Cancer Immunol Immunother 38: 75
104. Foon KA, Oseroff AR, Vaickus L, Greenberg SJ, Russell D, Bernstein Z, Pincus S, Köhler H, Seon NK, Tahaoglu E, Beers T, Chakraborty M, Bhattacharya-Chatterjee M (1995) Immune response in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-B cell antigen. Clin Cancer Res 11: 1285
105. Li WP, Zaloudik J, Gänczöl E, Ricciardi R, Berencsi K, Somasundaram R, Herlyn D (1994) Targeting of the CO17-1A/GA733 antigen in immunotherapy of colorectal carcinoma. In: Cancer vaccines: structural basis for vaccine development. Cancer Research Institute, New York, W61